Home › Stocks › PBLS › Changes

Who bought & sold PBLS (Q2 2026)

Funds holding (Q2 2026)82
New positions82
Added0
Reduced0
Exited0

As of Q2 2026, 82 institutional funds reported holding PBLS (PARABILIS MEDICINES INC): 82 opened new positions, 0 added, 0 trimmed and 0 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (20 of 82)

Fund Shares Value Weight
RA CAPITAL MANAGEMENT, L.P. New 28.93M $791.91M 6.9
Fidelity Management & Research (FMR) New 10.29M $281.71M 0.0
ARCH Venture Management, LLC New 6.41M $175.52M 16.0
venBio Partners LLC New 5.27M $144.15M 27.8
Alphabet Inc. New 4.92M $134.65M 0.1
Nextech Invest Ltd. New 4.66M $127.63M 6.1
Cormorant Asset Management, LP New 4.62M $126.33M 6.5
REGENERON PHARMACEUTICALS, INC. New 4.17M $114.04M 64.4
Siren, L.L.C. New 2.99M $81.90M 1.7
Farallon Capital Management New 2.37M $64.82M 0.3
FARALLON CAPITAL MANAGEMENT, L.L.C. New 2.37M $64.82M 0.3
Jupiter Topco LLC New 2.30M $62.71M 0.0
Frazier Life Sciences Management, L.P. New 1.92M $52.57M 1.1
DEERFIELD MANAGEMENT COMPANY, L.P. New 1.88M $51.47M 0.6
General Catalyst Group Management, LLC New 1.60M $43.82M 23.2
GENERAL ATLANTIC, L.P. New 1.54M $42.11M 1.4
Soleus Capital Management, L.P. New 1.47M $40.10M 1.4
VANGUARD PORTFOLIO MANAGEMENT LLC New 1.30M $35.65M 0.0
VANGUARD CAPITAL MANAGEMENT LLC New 1.16M $31.67M 0.0
JPMorgan Chase & Co New 1.04M $30.44M 0.0

Added to positions (0)

No adds this quarter.

Reduced positions (0)

No trims this quarter.

Exited positions (0)

No exits this quarter.